全文获取类型
收费全文 | 1468篇 |
免费 | 131篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 9篇 |
儿科学 | 62篇 |
妇产科学 | 50篇 |
基础医学 | 135篇 |
口腔科学 | 121篇 |
临床医学 | 165篇 |
内科学 | 328篇 |
皮肤病学 | 31篇 |
神经病学 | 60篇 |
特种医学 | 98篇 |
外科学 | 152篇 |
综合类 | 84篇 |
预防医学 | 145篇 |
眼科学 | 11篇 |
药学 | 106篇 |
中国医学 | 2篇 |
肿瘤学 | 49篇 |
出版年
2022年 | 10篇 |
2021年 | 16篇 |
2020年 | 16篇 |
2019年 | 18篇 |
2018年 | 22篇 |
2017年 | 14篇 |
2016年 | 26篇 |
2015年 | 33篇 |
2014年 | 34篇 |
2013年 | 36篇 |
2012年 | 44篇 |
2011年 | 49篇 |
2010年 | 49篇 |
2009年 | 55篇 |
2008年 | 69篇 |
2007年 | 56篇 |
2006年 | 81篇 |
2005年 | 46篇 |
2004年 | 60篇 |
2003年 | 30篇 |
2002年 | 37篇 |
2001年 | 38篇 |
2000年 | 34篇 |
1999年 | 31篇 |
1998年 | 52篇 |
1997年 | 40篇 |
1996年 | 54篇 |
1995年 | 23篇 |
1994年 | 24篇 |
1993年 | 26篇 |
1992年 | 35篇 |
1991年 | 36篇 |
1990年 | 25篇 |
1989年 | 27篇 |
1988年 | 40篇 |
1987年 | 32篇 |
1986年 | 22篇 |
1985年 | 33篇 |
1984年 | 22篇 |
1983年 | 13篇 |
1980年 | 14篇 |
1978年 | 13篇 |
1977年 | 15篇 |
1976年 | 14篇 |
1975年 | 13篇 |
1974年 | 15篇 |
1972年 | 10篇 |
1971年 | 13篇 |
1967年 | 10篇 |
1966年 | 9篇 |
排序方式: 共有1608条查询结果,搜索用时 15 毫秒
141.
142.
143.
Parathyroid adenomas evaluated by Tl-201/Tc-99m pertechnetate subtraction scintigraphy and high-resolution ultrasonography 总被引:2,自引:0,他引:2
Winzelberg GG; Hydovitz JD; O'Hara KR; Anderson KM; Turbiner E; Danowski TS; Lippe RD; Melada GA; Harrison AM 《Radiology》1985,155(1):231-235
Thallium-201/technetium-99m pertechnetate subtraction scintigraphy of the parathyroid glands was performed in a prospective study of 33 patients who had undergone bilateral neck exploration for elevated serum calcium and serum parathyroid hormone levels. In 31 cases, the Tl-201/Tc-99m subtraction technique yielded an overall sensitivity of 81%, specificity of 99%, and accuracy of 94% for identifying solitary parathyroid adenomas. Tl-201/Tc-99m subtraction scintigraphy correctly identified 73% of parathyroid adenomas weighing less than 499 mg, 79% of those weighing 500-1,499 mg, and 100% of adenomas weighing more than 1,500 mg. In a subgroup of 24 patients with solitary parathyroid adenomas who underwent both scintigraphy and high-resolution sonography, the sensitivity, specificity, and accuracy of both procedures were similar. 相似文献
144.
145.
146.
Retigabine is a novel anticonvulsant with an unknown mechanism of action. It has recently been reported that retigabine modulates a potassium channel current in nerve growth factor-differentiated PC12 cells (), however, to date the molecular correlate of this current has not been identified. In the present study we have examined the effects of retigabine on recombinant human KCNQ2 and KCNQ3 potassium channels, expressed either alone or in combination in Xenopus oocytes. Application of 10 microM retigabine to oocytes expressing the KCNQ2/3 heteromeric channel shifted both the activation threshold and voltage for half-activation by approximately 20 mV in the hyperpolarizing direction, leading to an increase in current amplitude at test potentials between -80 mV and +20 mV. Retigabine also had a marked effect on KCNQ current kinetics, increasing the rate of channel activation but slowing deactivation at a given test potential. Similar effects of retigabine were observed in oocytes expressing KCNQ2 alone, suggesting that KCNQ2 may be the molecular target of retigabine. Membrane potential recordings in oocytes expressing the KCNQ2/3 heteromeric channel showed that application of retigabine leads to a concentration-dependent hyperpolarization of the oocyte, from a resting potential of -63 mV under control conditions to -85 mV in the presence of 100 microM retigabine (IC(50) = 5.2 microM). In control experiments retigabine had no effect on either resting membrane potential or endogenous oocyte membrane currents. In conclusion, we have shown that retigabine acts as a KCNQ potassium channel opener. Because the heteromeric KCNQ2/3 channel has recently been reported to underlie the M-current, it is likely that M-current modulation can explain the anticonvulsant actions of retigabine in animal models of epilepsy. 相似文献
147.
148.
Human burst-forming units-erythroid need direct interaction with stem cell factor for further development 总被引:6,自引:3,他引:6
To understand the factors that regulate the early growth and development of immature erythroid progenitor cells, the burst-forming units-erythroid (BFU-E), it is necessary to have both highly purified target cells and a medium free of serum. When highly purified human blood BFU-E were cultured in a serum-free medium adequate for the growth of later erythroid progenitors, BFU-E would not grow even with the addition of recombinant human interleukin-3 (rIL-3), known to be essential for these cells. However, the addition of recombinant human stem cell factor (rSCF), which supports germ cell and pluripotential stem cell growth, stimulated BFU-E to grow equally well in serum-free as in serum-containing medium. Limiting dilution studies showed that rSCF acts directly on the BFU-E that do not require accessory cells for growth. Furthermore, rSCF was necessary for BFU-E development during the initial 7 days of culture, until these cells reached the stage of the late progenitors, the colony-forming units-erythroid (CFU-E). These studies indicate that early erythropoiesis is dependent on the direct action of SCF that not only affects early stem cells but is continually necessary for the further development of committed erythroid progenitor cells until the CFU-E stage of maturation. 相似文献
149.
150.